Effects of N-glycans on the structure of human IgA2
The transition of IgA antibodies into clinical development is crucial because they have the potential to create a new class of therapeutics with superior pathogen neutralization, cancer cell killing, and immunomodulation capacity compared to IgG. However, the biological role of IgA glycans in these...
Main Authors: | Valentina Ruocco, Clemens Grünwald-Gruber, Behzad Rad, Rupert Tscheliessnig, Michal Hammel, Richard Strasser |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-04-01
|
Series: | Frontiers in Molecular Biosciences |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2024.1390659/full |
Similar Items
-
Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy
by: Yan-feng Zhao, et al.
Published: (2017-09-01) -
Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy
by: Koshi Yamada, et al.
Published: (2017-11-01) -
IgA1 dominant subclass of latent IgA mesangial deposition in donated kidney
by: Oka K, et al.
Published: (2016-11-01) -
Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
by: Yoshihito Nihei, et al.
Published: (2023-04-01) -
IgA Antibodies and IgA Deficiency in SARS-CoV-2 Infection
by: Isabella Quinti, et al.
Published: (2021-04-01)